27th Jan 2025 10:04
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.
----------
AIM - WINNERS
----------
Good Energy Group PLC, up 21% at 478.18 pence, 12-month range 232.00p-484.69p. It has accepted a GBP99.4 million takeover offer from UAE-based suitor Esyasoft Holding Ltd, which sweetened its bid after an approach in October. Esyasoft's new offer for the Chippenham, England-based renewable electricity supplier and energy services provider is 490 pence per share in cash. It values Good Energy's equity at GBP99.4 million and implies an enterprise value of GBP67.8 million. In October, Esyasoft had made an approach at 412p per share. Good Energy said that tilt "was not a fair reflection of the future growth opportunities of the company". The new offer is a 66% premium to Good Energy's share price of 295p before Esyasoft's approach in October and 24% above Friday's close.
----------
hVIVO PLC, up 6.8% at 20.92 pence, 12-month range 16.50p-32.00p. The London-based contract research organisation has been picked to conduct a "large-scale" phase 3 human challenge trial. The trial is for the ILiAD Biotechnologies vaccine candidate BPZE1 for whooping cough. It will be hVIVO's largest human challenge trial to date and is expected to begin in the second half.
----------
AIM - LOSERS
----------
Ondine Biomedical Inc, down 10% at 11.44p, 12-month range 5.00p-13.30p. HCA Healthcare has invested USD4 million in the life sciences company. Ondine will issue 38.0 million shares at USD0.10517 each. Elsewhere, the settlement of a placement with a Canadian private investor remains delayed. "Ondine entered into a private placement agreement with a Canadian private investor in September 2024. Due to the investor's unavoidable personal circumstances, settlement of the private placement continues to be delayed. The company remains optimistic about the completion of this placement and will provide further updates as they become available," Ondine adds.
----------
By Eric Cunha, Alliance News news editor
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.